PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Queen\'s University, Kingston, ON. Electronic address: robert.reid@queensu.ca.\', \'Department of Obstetrics, Gynecology and Reproductive Sciences, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB.\', \'Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON; Department of Internal Medicine (Endocrinology), University of Toronto, Toronto, ON.\', \'Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1701-2163(19)30981-810.1016/j.jogc.2019.10.039
?:doi
?:hasPublicationType
?:journal
  • Journal of obstetrics and gynaecology Canada : JOGC = Journal d\'obstetrique et gynecologie du Canada : JOGC
is ?:pmid of
?:pmid
?:pmid
  • 31932249
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.6
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of Menopause.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/31932249>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/31932249>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all